GlassScriptPhysician profile
Lourdes Virtusio
NPI 1144249012
$2,071.06
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $976 · 2020: $89.40 · 2021: $52.79 · 2022: $102 · 2023: $540 · 2024: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $850.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $633.10 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $257.06 | 2019-2024 | Jardiance |
| Novo Nordisk INC | $220.85 | 2019-2022 | |
| Lilly USA, LLC | $168.98 | 2019-2024 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $135.72 | 2019-2024 | |
| Astellas Pharma US INC | $101.86 | 2019-2024 | Veozah |
| Glaxosmithkline, LLC. | $99.98 | 2019-2023 | Trelegy Ellipta |
| Pfizer INC. | $89.60 | 2019-2024 | |
| Amarin Pharma, INC. | $78.72 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $65.68 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $37.48 | 2019 | |
| Allergan, INC. | $29.99 | 2019 | |
| Sanofi-Aventis U.S. LLC | $26.64 | 2019 | |
| Abbott Laboratories | $23.29 | 2024 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $22.02 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.66 | 2019 | |
| Abbvie INC. | $19.46 | 2019 | |
| Sunovion Pharmaceuticals INC. | $16.58 | 2019 | |
| Idorsia Pharmaceuticals US INC | $12.86 | 2023 | Quviviq |
| Kowa Pharmaceuticals America, INC. | $11.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lourdes Virtusio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.